uracil has been researched along with Uterine Cervical Neoplasms in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (50.00) | 18.7374 |
| 1990's | 8 (30.77) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukumatsu, Y; Katabuchi, H; Mimori, H; Motohara, T; Saito, F; Sakaguchi, I; Shibata, S; Takaishi, K; Tashiro, H; Tohya, T | 1 |
| Eda, H; Endoh, M; Hattori, K; Horii, I; Ishikawa, T; Ishitsuka, H; Kawashima, A; Kohchi, Y; Miwa, M; Oikawa, N; Shimma, N; Suda, H; Tanimura, H; Ura, M | 1 |
| CAVANAGH, D; FERGUSON, JH; MARTIN, DS | 1 |
| Kamnerdsupaphon, P; Khorprasert, C; Lertsanguansinchai, P; Lorvidhaya, V; Sangruchi, S; Sookpreedee, L; Suntornpong, N; Udompunturak, S; Veerasarn, V | 1 |
| Hirata, E; Jin, HH; Komatsu, M; Mukai, K; Nagai, N; Yunokawa, M | 1 |
| Hatae, M; Hokanishi, H; Terahara, M | 1 |
| Hoshino, K; Mitsuya, T; Morioka, M; Noguchi, Y; Notake, Y; Okuyama, D; Shimizu, A; Takahashi, J; Watanabe, S; Yoda, A | 1 |
| Aida, I; Kasuga, Y; Ohwada, M; Sato, I; Suzuki, M; Tamura, T | 1 |
| Hidaki, T; Kato, T; Sugimori, H; Tazaki, T; Tsukamoto, N; Yakushiji, M; Yamabe, T | 1 |
| Foksinski, M; Jaruga, P; Makarewicz, R; Olinski, R | 1 |
| Miyaoka, S; Nagai, N; Ohama, K; Oshita, T; Shigemasa, K; Takehara, K | 1 |
| Shiota, M; Shirai, T; Tateyama, I | 1 |
| Ibuki, Y; Igarashi, M; Ito, T; Kimura, H; Kosuge, T; Nagayama, M; Nogami, Y; Ohwada, N; Tsukagoshi, T; Yazaki, K | 1 |
| Adachi, S; Akaza, H; Ishitsuka, H; Kanazawa, K; Miwa, M; Nitta, K; Sekiguchi, F; Tokita, H | 1 |
| Sekiguchi, I; Suzuki, M; Tamada, T | 1 |
| Hieda, S; Ishihara, M; Noguchi, M; Sawaguchi, K; Ueno, N; Yabushita, H | 1 |
| Inoue, K; Mitani, K; Morishita, Y; Yamashita, K | 1 |
| Fujiwara, K; Inoue, K; Kaneshige, E; Kobashi, Y; Kono, I; Sekiba, K; Tanimura, T | 1 |
| Kamiya, H; Nagai, S; Sakai, K; Sato, K | 1 |
| Ikeda, M; Kaneshige, E; Kohno, I; Matsuoka, I; Noda, K; Sawaragi, I; Sekiba, K; Sugawa, T; Teshima, K; Yamagata, S | 1 |
| Aiko, A; Fukuma, K; Ikuta, Y; Inoue, S; Matsuura, K; Okumura, A; Onitsuka, Y; Shibata, S; Tanaka, T; Yoshimura, T | 1 |
| Hirano, H; Kawai, Y; Nishiyama, M; Sugiyama, Y; Taniguchi, H; Uematsu, A; Yanase, H | 1 |
| Ohwada, M; Sekiguchi, I; Suzuki, M; Tamada, T | 1 |
| Kosoĭ, GKh | 1 |
| Kholodnyi, MD; Mindlin, SS | 1 |
| Klunichenko, AM | 1 |
6 trial(s) available for uracil and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Retrospective Studies; Tegafur; Treatment Outcome; Uracil; Uterine Cervical Neoplasms | 2015 |
A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: preliminary results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Female; Humans; Middle Aged; Prospective Studies; Tegafur; Uracil; Uterine Cervical Neoplasms | 2007 |
[5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; Fluorouracil; Humans; Lymph Nodes; Middle Aged; Tegafur; Uracil; Uterine Cervical Neoplasms | 1995 |
[A multicenter cooperative study on supplementary chemotherapy of uterocervical cancer. The Kyushu UFT Study Group of Uterocervical Cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Middle Aged; Survival Rate; Tegafur; Uracil; Uterine Cervical Neoplasms | 1994 |
[Maintenance chemotherapy using UFT and FT for gynecological malignant tumors. The Gunma Prefectural Society for Study of Chemotherapy for Gynecological Cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Ovarian Neoplasms; Survival Rate; Tegafur; Uracil; Uterine Cervical Neoplasms; Uterine Neoplasms | 1992 |
[Phase II study of UFT in cancer of the uterine cervix].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Middle Aged; Tegafur; Uracil; Uterine Cervical Neoplasms | 1985 |
20 other study(ies) available for uracil and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Non-Small-Cell Lung; Cytidine Deaminase; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Design; Drug Stability; Esterases; Female; Fluorouracil; Humans; Lung Neoplasms; Mice; Oxidoreductases; Prodrugs; Thymidine Phosphorylase; Tissue Distribution; Uracil; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2003 |
CLOSED PELVIC PERFUSION IN ADVANCED GYNECOLOGIC CANCER.
Topics: Catheterization; Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Female; Fluorouracil; Folic Acid; Genital Neoplasms, Female; Geriatrics; Humans; Lymphography; Neoplasms; Nitrogen Mustard Compounds; Palliative Care; Pelvis; Postoperative Care; Prognosis; Toxicology; Uracil; Uracil Mustard; Urography; Uterine Cervical Neoplasms; Vulvar Neoplasms | 1965 |
UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma.
Topics: 4-Butyrolactone; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Immunohistochemistry; Middle Aged; Tegafur; Uracil; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2008 |
[Comparative pharmacokinetic study between UFT and FT-207 suppo and phase II studies in gynecological malignancies].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Fluorouracil; Humans; Kinetics; Middle Aged; Tegafur; Uracil; Uterine Cervical Neoplasms; Uterine Neoplasms | 1984 |
[A case report: complete remission of stage IV uterine cervix carcinoma by immuno-chemotherapy with intraarterial infusion using implantable reservoir system].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Hysterectomy; Immunotherapy; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Lymph Node Excision; Picibanil; Remission Induction; Tegafur; Uracil; Uterine Cervical Neoplasms | 1995 |
Oxidative DNA base damage in cancerous tissues of patients undergoing brachytherapy.
Topics: Adenine; Brachytherapy; Cytosine; DNA Damage; DNA, Neoplasm; Female; Gas Chromatography-Mass Spectrometry; Guanine; Humans; Oxidation-Reduction; Pyrimidines; Uracil; Uterine Cervical Neoplasms | 1998 |
[A case of uterine cervical cancer in which UFT was an effective preoperative treatment].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Preoperative Care; Tegafur; Uracil; Uterine Cervical Neoplasms | 1999 |
[A patient with recurrent uterine cervical cancer successfully treated by combined modality therapy including local injection of anticancer agents based on CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Injections, Intralesional; Muscle Neoplasms; Tegafur; Uracil; Uterine Cervical Neoplasms | 2000 |
[Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; Fluorouracil; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1991 |
Thymidylate synthase inhibition as a predictor of tumor sensitivity of fluorinated pyrimidines.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Mice; Middle Aged; Subrenal Capsule Assay; Tegafur; Thymidylate Synthase; Uracil; Uterine Cervical Neoplasms | 1990 |
[Experimental study on the effect of UFT with concomitant radiotherapy of uterine cervical cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Line; Combined Modality Therapy; DNA Polymerase II; Female; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Tegafur; Tumor Cells, Cultured; Uracil; Uterine Cervical Neoplasms | 1989 |
[The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Middle Aged; Tegafur; Tissue Distribution; Uracil; Uterine Cervical Neoplasms | 1989 |
[5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; Humans; Kinetics; Middle Aged; Ovary; Tegafur; Uracil; Uterine Cervical Neoplasms | 1986 |
[In vitro effects of 5-FU on gynecologic malignant tumor cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Line; Cells, Cultured; Colony-Forming Units Assay; Female; Fluorouracil; Humans; Ovarian Neoplasms; Tegafur; Tumor Stem Cell Assay; Uracil; Uterine Cervical Neoplasms | 1986 |
[UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrium; Female; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Ovary; Tegafur; Uracil; Uterine Cervical Neoplasms; Uterine Neoplasms | 1985 |
[A study on plasma and tissue 5-FU concentrations in patients with cervical cancer treated with UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Tegafur; Uracil; Uterine Cervical Neoplasms | 1985 |
[Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cervix Uteri; Female; Fluorouracil; Humans; Middle Aged; Tegafur; Uracil; Uterine Cervical Neoplasms | 1985 |
[On the effect of methyluracil and Pentoxyl on induction of cancer of the uterine cervix and vagina in mice].
Topics: Animals; Benz(a)Anthracenes; Colchicine; Female; Glycols; Mice; Neoplasms, Experimental; Thiotepa; Uracil; Uterine Cervical Neoplasms; Vaginal Neoplasms | 1968 |
[The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds].
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Female; Hematologic Diseases; Hematopoiesis; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Mannomustine; Middle Aged; Neoplasms; Nitrogen Mustard Compounds; Ovarian Neoplasms; Phosphates; Phosphines; Stomach Neoplasms; Thiotepa; Uracil; Uterine Cervical Neoplasms | 1969 |
[The use of pentoxyl in radium therapy of malignant neoplasms of female genitalia].
Topics: Adult; Female; Humans; Middle Aged; Radium; Rectal Neoplasms; Uracil; Uterine Cervical Neoplasms; Uterine Neoplasms | 1966 |